4MO_PR HER2-low breast cancer: Evolution from primary breast cancer to relapse

MLA

Pierfranco Conte, et al. “4MO_PR HER2-Low Breast Cancer: Evolution from Primary Breast Cancer to Relapse.” Annals of Oncology, vol. 32, May 2021, p. S23. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........43438bf5f9ebc1a4db352ab7a5d0229a&authtype=sso&custid=ns315887.

APA

Pierfranco Conte, Elisa Genovesi, Valentina Guarneri, M. Lo Mele, Grazia Vernaci, Federica Miglietta, Gaia Griguolo, Maria Vittoria Dieci, D. De Bartolo, Michele Bottosso, Tommaso Giarratano, Matteo Fassan, & Matilde Cacciatore. (2021). 4MO_PR HER2-low breast cancer: Evolution from primary breast cancer to relapse. Annals of Oncology, 32, S23.

Chicago

Pierfranco Conte, Elisa Genovesi, Valentina Guarneri, M. Lo Mele, Grazia Vernaci, Federica Miglietta, Gaia Griguolo, et al. 2021. “4MO_PR HER2-Low Breast Cancer: Evolution from Primary Breast Cancer to Relapse.” Annals of Oncology 32 (May): S23. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........43438bf5f9ebc1a4db352ab7a5d0229a&authtype=sso&custid=ns315887.